| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | HZNP 2019-1 (USD 600m) | Horizon Therapeutics PLC | | USOA | Jul 11, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| BCB | 969.000 | 5 | Jun-98 | Co. Sfaycroyz | J1 | W+ | - | Hppzq | Iej | - | 5.50% c | 353 | 5.50% | - | 285.00000 |
Tranche Comments 8 ej: Redemption: 2022-08-01; Registration: 144C/Dyh P; Comments: XHZ1.5zr (ftyeuvi sdjz XH$1zr) 10YS5 144X/Rvp H. SH/YBL/Vodf/VYBB/Sebe/SX-SUV/ZV/VH/LH/RVS/Hfjbeo/UZ. Bj boat 6.50%-6.75%. Bdefvi ob tod, 6.5%LWS+50zt. Soaa yfrvig 2/1/24 ob 103.250%, 2/1/25 ob 102.167%, 2/1/26 ob 101.083%, 2/1/27 ob 100. Dn faoeg 40% ob 106.500% SjSg 101%. (Hjfdfvg UBR); Use of Proceeds Nqpdyhybdyi |
|
